Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
IDT Australia Limited (AU:IDT)
ASX:IDT
IDT Australia Limited (IDT) Share Price & Analysis
1 Followers
IDT Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.05 - AU$0.15
Previous CloseAU$0.13
Volume29.99K
Average Volume (3M)394.78K
Market Cap
AU$53.74M
Enterprise ValueAU$45.41M
Total Cash (Recent Filing)AU$9.21M
Total Debt (Recent Filing)AU$881.00K
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Aug 27, 2024EPS EstimateN/A
Last Dividend Ex-Date
Apr 12, 2010Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding351,479,469
10 Day Avg. Volume180,237
30 Day Avg. Volume394,776
Standard Deviation0.18
R-Squared0.06
Alpha-0.00251
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
IDT Australia Limited News
PremiumCompany Announcements
Sandon Capital Boosts Stake in IDT Australia
PremiumCompany Announcements
IDT Australia Expands Market Presence with New SharesPremiumCompany Announcements
IDT Australia Launches $7 Million Capital Raise
PremiumCompany Announcements
Bank of America Exits Stake in IDT Australia
PremiumCompany Announcements
IDT Australia Corrects Securities Issue Details
PremiumCompany Announcements
IDT Australia Limited Announces $7M Capital RaisePremiumCompany Announcements
IDT Australia Plans 50M Share IssuePremiumCompany Announcements
IDT Australia Eyes Growth with $7M Capital RaiseOptions Prices
Currently, No data available
---
Ownership Overview
4.96% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
95.04% Public Companies and
Individual Investors
IDT FAQ
What was IDT Australia Limited’s price range in the past 12 months?
IDT Australia Limited lowest share price was AU$0.05 and its highest was AU$0.14 in the past 12 months.
What is IDT Australia Limited’s market cap?
Currently, no data Available
When is IDT Australia Limited’s upcoming earnings report date?
IDT Australia Limited’s upcoming earnings report date is Aug 27, 2024 which is in 35 days.
How were IDT Australia Limited’s earnings last quarter?
IDT Australia Limited released its earnings results on Feb 21, 2024. The company reported -AU$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.011.
Is IDT Australia Limited overvalued?
According to Wall Street analysts IDT Australia Limited’s price is currently Overvalued.
Does IDT Australia Limited pay dividends?
IDT Australia Limited pays a Annually dividend of <AU$0.01 which represents an annual dividend yield of N/A. See more information on IDT Australia Limited dividends here
What is IDT Australia Limited’s EPS estimate?
IDT Australia Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IDT Australia Limited have?
IDT Australia Limited has 429,587,740 shares outstanding.
What happened to IDT Australia Limited’s price movement after its last earnings report?
IDT Australia Limited reported an EPS of -AU$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10%.
Which hedge fund is a major shareholder of IDT Australia Limited?
Currently, no hedge funds are holding shares in AU:IDT
---
IDT Australia Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
94.02%
12-Months-Change
Fundamentals
Return on Equity
-27.94%
Trailing 12-Months
Asset Growth
8.15%
Trailing 12-Months
Company Description
IDT Australia Limited
IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services.
---
Technical Analysis
---